Vivlodex

Active Ingredient(s): Meloxicam
FDA Approved: * October 22, 2015
Pharm Company: * IROKO PHARMS LLC
Category: Arthritis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Vivlodex Overview

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and anti-pyretic effects. It is an oxicam closely related to piroxicam, and falls in the enolic acid group of NSAIDs.[2] It was developed by Boehringer-Ingelheim. Meloxicam starts to relieve pain about 30–60 minutes after administration.[3] As of 2015 the cost for a typical month of medication in the United States is less than $25 USD.[4] Contents 1 Adverse effec...

Read more Vivlodex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Meloxicam

Recent Vivlodex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Vivlodex: (2 results)

Sorted by National Drug Code

• 42211-205 Vivlodex 5 mg Oral Capsule by Iroko Pharmaceuticals, LLC
• 42211-206 Vivlodex 10 mg Oral Capsule by Iroko Pharmaceuticals, LLC

Other drugs which contain Meloxicam or a similar ingredient: (2 results)

• MELOXICAM 331 discussions
• MOBIC Meloxicam41 discussions